Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
SWS Hemodialysis Care CoSHSE:688410 -3.35%84 5-Year Yield-on-Cost % is 1.99 as of Sep. 01, 2026, which is 93% above its 10-year median of 1.03. GuruFocus rates SHSE:688410 with a GF Score™ of 84/100 and a GF Value™ of ¥17.51 (Significantly Undervalued). The stock has 1 warning sign investors should review. Among 316 Medical Devices & Instruments companies, SWS Hemodialysis Care Co ranks worse than 56.33% on this metric.
The historical rank and industry rank for SWS Hemodialysis Care Co's 5-Year Yield-on-Cost % or its related term are showing as below:
SHSE:688410'
s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.41 Med: 1.03 Max: 3.1
Current: 1.99
During the past 12 years, SWS Hemodialysis Care Co's highest Yield on Cost was 3.10. The lowest was 0.41. And the median was 1.03.
SHSE:688410's 5-Year Yield-on-Cost % is ranked worse than 56.33% of 316
companies
in the Medical Devices & Instruments industry
Industry Median: 2.385
vs SHSE:688410: 1.99
SWS Hemodialysis Care Co (SHSE:688410) 5-Year Yield-on-Cost % Explanation
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
SWS Hemodialysis Care Co 5-Year Yield-on-Cost % Related Terms
SHSE:688410 vs ISRG, BDX, RMD: 5-Year Yield-on-Cost % Comparison
For the Medical Instruments & Supplies subindustry, SWS Hemodialysis Care Co's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
SWS Hemodialysis Care Co 5-Year Yield-on-Cost % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, SWS Hemodialysis Care Co's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where SWS Hemodialysis Care Co's 5-Year Yield-on-Cost % falls into.
SWS Hemodialysis Care Co 5-Year Yield-on-Cost % Calculation
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
SWS Hemodialysis Care Co (SHSE:688410) has a 5-Year Yield-on-Cost % of 1.99 as of Sep. 01, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on SWS Hemodialysis Care Co and its competitors. This is 93% above median its historical median of 1.03. Over the past decade, SWS Hemodialysis Care Co's 5-Year Yield-on-Cost % has ranged from 0.41 to 3.10. According to the industry distribution chart, SWS Hemodialysis Care Co ranks #178 out of 316 companies in the Medical Devices & Instruments industry, placing it in the top 56.3%.
Is SWS Hemodialysis Care Co's 5-Year Yield-on-Cost % too high?
SWS Hemodialysis Care Co's current 5-Year Yield-on-Cost % of 1.99 is 93% above median its 10-year median of 1.03. Over the past 10 years, this metric has ranged from a low of 0.41 to a high of 3.10. The Medical Devices & Instruments industry median 5-Year Yield-on-Cost % is 2.39. SWS Hemodialysis Care Co's value of 1.99 is 16.6% below this industry median. Based on the distribution chart, SWS Hemodialysis Care Co ranks #178 out of 316 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, SWS Hemodialysis Care Co has a GF Score™ of 84/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does SWS Hemodialysis Care Co's 5-Year Yield-on-Cost % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, SWS Hemodialysis Care Co ranks #178 out of 316 companies for 5-Year Yield-on-Cost %. This places SWS Hemodialysis Care Co in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 2.39. SWS Hemodialysis Care Co's value of 1.99 is 16.6% below this benchmark. Historically, SWS Hemodialysis Care Co's own 5-Year Yield-on-Cost % has ranged from 0.41 to 3.10 over the past decade. While the company's 10-year median is 1.03 vs. the industry median of 2.39, SWS Hemodialysis Care Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Medical Devices & Instruments company?
The median 5-Year Yield-on-Cost % among Medical Devices & Instruments companies is 2.39, based on 316 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. SWS Hemodialysis Care Co's current 5-Year Yield-on-Cost % of 1.99 is 16.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on SWS Hemodialysis Care Co and its competitors. For the Medical Devices & Instruments industry, the median 5-Year Yield-on-Cost % is 2.39 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. SWS Hemodialysis Care Co's current 5-Year Yield-on-Cost % is 1.99, which is 93% above median its own 10-year median of 1.03. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SWS Hemodialysis Care Co stock overvalued right now?
Based on GuruFocus' analysis, SWS Hemodialysis Care Co (SHSE:688410) is currently considered Significantly Undervalued. The stock's GF Value™ is ¥17.51, compared to a current price of ¥10.09 — trading 42.4% below its estimated fair value. The current 5-Year Yield-on-Cost % is 1.99, which is 93% above median its 10-year median of 1.03 and 16.6% below the Medical Devices & Instruments industry median of 2.39. SWS Hemodialysis Care Co's overall GF Score™ is 84/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For SWS Hemodialysis Care Co (SHSE:688410), the current 5-Year Yield-on-Cost % is 1.99 as of Sep. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is SWS Hemodialysis Care Co (SHSE:688410) Overvalued in 2026?
Based on GuruFocus' analysis, SWS Hemodialysis Care Co stock appears to be undervalued.
The current stock price of ¥10.09 is trading 42.4% below its estimated GF Value™ of ¥17.51.
GuruFocus considers SWS Hemodialysis Care Co to be Significantly Undervalued.
Key valuation signals for SHSE:688410:
5-Year Yield-on-Cost %: 1.99 (93% above median its 10-year median of 1.03)
GF Value™: ¥17.51 vs. price of ¥10.09 (42.4% below fair value)
Industry Position: 16.6% below the Medical Devices & Instruments median (#178 of 316)
No single metric tells the full story. See the SHSE:688410 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
SWS Hemodialysis Care Co Ltd along with its subsidiaries is engaged in the field of blood purification. Its focused on patients welfare and ensuring the delivery of safe and effective products and services. The group operates through four segments: Blood Purification Equipment, Blood Purification Consumables, advanced Hemodialysis Management System, and Chain Dialysis centers. The organization is delivering medical solutions for patients with chronic kidney disease (CKD). Its products include Blood Purification Equipment Dialysis, Disposables Dialysis Center, Intelligent Management System, and Chain Dialysis centers. SWS is committed to enhancing patient wellness by prioritizing care through advanced integrated blood purification technologies.
84GF Score
Get the complete analysis for SHSE:688410
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688410 has been successfully added to your 
